The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman ...
The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...
ScienceAlert on MSN
Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already
Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...
5don MSN
A newly-discovered mechanism could contribute to the therapeutic effects of deep brain stimulation
Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to ...
Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.
Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...
Doctors noticed an instant improvement in Parkinson’s disease patient Denise Bacon’s mobility during the procedure, known as Deep Brain Stimulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback